Radoslav I Raychev1,2, Dana Stradling3, Nirav Patel4, Joey R Gee5, David A Lombardi6, Johnson L Moon7, David M Brown8, Mayank Pathak9, Wengui Yu3, Samuel J Stratton10,11, Steven C Cramer12. 1. From the Saddleback Memorial Medical Center, Laguna Hills, CA (R.I.R.). 2. Department of Neurology, University of California, Los Angeles (R.I.R.). 3. Department of Neurology, University of California, Irvine (D.S., W.Y., S.C.C.). 4. Los Alamitos Medical Center, CA (N.P.). 5. Mission Hospital, Mission Viejo, CA (J.R.G.). 6. Orange County Global Medical Center, Santa Ana, CA (D.A.L.). 7. St. Jude Medical Center, Fullerton, CA (J.L.M.). 8. Hoag Neurosciences Institute, Hoag Memorial Hospital, Newport Beach, CA (D.M.B.). 9. St. Joseph Hospital, Orange, CA (M.P.). 10. Orange County Emergency Medical Services, Santa Ana, CA (S.J.S.). 11. Department of Community Health Sciences (S.J.S.). 12. Department of Neurology, University of California, Irvine (D.S., W.Y., S.C.C.) scramer@uci.edu.
Abstract
BACKGROUND AND PURPOSE: In Orange County, California, patients with suspected acute stroke are taken to stroke neurology receiving centers that are designated by County Emergency Medical Services authorities as either hubs or spokes based on endovascular treatment capability. We examined relationships between stroke details, reperfusion therapies, hospital transfers, and their change over time. METHODS: All patients from January 1, 2013, to December 31, 2015, for whom 911 was called within 7 hours of onset in whom Emergency Medical Services personnel suspected acute stroke were evaluated. RESULTS: Among 6132 patients, 3924 (64%) had confirmed diagnosis of stroke (74% ischemic/26% hemorrhagic), yielding diagnostic precision of 64% in the field. Of the 2892 patients with acute ischemic stroke, acute reperfusion therapy was given to 29.2% (21.7% intravenous tPA [tissue-type plasminogen activator] only and 7.5% endovascular treatment). Rates of endovascular treatment of patients with ischemic stroke increased over time, more than doubling from 5.6% in 2013 to 12.5% (odds ratio per 3-month quarter=1.09; 95% confidence interval, 1.04-1.14; P<0.0001). Only 3.4% of patients with acute ischemic stroke were transferred from a spoke to a hub hospital; transfer rates were inversely related to age (P<0.0001), and reperfusion therapy rates did not vary according to transfer status. CONCLUSIONS: Favorable features of this acute stroke care system include reperfusion therapy in 29.2% of patients with ischemic stroke and substantial increases in endovascular treatment rates over time. Continued efforts to optimize acute stroke systems of care can be directed toward improving access to best acute stroke therapies.
BACKGROUND AND PURPOSE: In Orange County, California, patients with suspected acute stroke are taken to stroke neurology receiving centers that are designated by County Emergency Medical Services authorities as either hubs or spokes based on endovascular treatment capability. We examined relationships between stroke details, reperfusion therapies, hospital transfers, and their change over time. METHODS: All patients from January 1, 2013, to December 31, 2015, for whom 911 was called within 7 hours of onset in whom Emergency Medical Services personnel suspected acute stroke were evaluated. RESULTS: Among 6132 patients, 3924 (64%) had confirmed diagnosis of stroke (74% ischemic/26% hemorrhagic), yielding diagnostic precision of 64% in the field. Of the 2892 patients with acute ischemic stroke, acute reperfusion therapy was given to 29.2% (21.7% intravenous tPA [tissue-type plasminogen activator] only and 7.5% endovascular treatment). Rates of endovascular treatment of patients with ischemic stroke increased over time, more than doubling from 5.6% in 2013 to 12.5% (odds ratio per 3-month quarter=1.09; 95% confidence interval, 1.04-1.14; P<0.0001). Only 3.4% of patients with acute ischemic stroke were transferred from a spoke to a hub hospital; transfer rates were inversely related to age (P<0.0001), and reperfusion therapy rates did not vary according to transfer status. CONCLUSIONS: Favorable features of this acute stroke care system include reperfusion therapy in 29.2% of patients with ischemic stroke and substantial increases in endovascular treatment rates over time. Continued efforts to optimize acute stroke systems of care can be directed toward improving access to best acute stroke therapies.
Authors: Steven C Cramer; Dana Stradling; David M Brown; Ignacio M Carrillo-Nunez; Anthony Ciabarra; Michael Cummings; Richard Dauben; David L Lombardi; Nirav Patel; Elizabeth N Traynor; Stephen Waldman; Ken Miller; Samuel J Stratton Journal: Stroke Date: 2012-01-26 Impact factor: 7.914
Authors: Maxim Mokin; Rishi Gupta; Waldo R Guerrero; David Z Rose; William S Burgin; Sananthan Sivakanthan Journal: J Neurointerv Surg Date: 2016-04-22 Impact factor: 5.836
Authors: Mahesh V Jayaraman; Arshad Iqbal; Brian Silver; Matthew S Siket; Caryn Amedee; Ryan A McTaggart; Gino Paolucci; Jason Rhodes; John Potvin; Megan Tucker; Nicole Alexander-Scott Journal: J Neurointerv Surg Date: 2016-03-03 Impact factor: 5.836
Authors: Mayank Goyal; Bijoy K Menon; Wim H van Zwam; Diederik W J Dippel; Peter J Mitchell; Andrew M Demchuk; Antoni Dávalos; Charles B L M Majoie; Aad van der Lugt; Maria A de Miquel; Geoffrey A Donnan; Yvo B W E M Roos; Alain Bonafe; Reza Jahan; Hans-Christoph Diener; Lucie A van den Berg; Elad I Levy; Olvert A Berkhemer; Vitor M Pereira; Jeremy Rempel; Mònica Millán; Stephen M Davis; Daniel Roy; John Thornton; Luis San Román; Marc Ribó; Debbie Beumer; Bruce Stouch; Scott Brown; Bruce C V Campbell; Robert J van Oostenbrugge; Jeffrey L Saver; Michael D Hill; Tudor G Jovin Journal: Lancet Date: 2016-02-18 Impact factor: 79.321
Authors: Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Blaise W Baxter; Thomas G Devlin; Demetrius K Lopes; Vivek K Reddy; Richard du Mesnil de Rochemont; Oliver C Singer; Reza Jahan Journal: N Engl J Med Date: 2015-04-17 Impact factor: 91.245
Authors: Henry Zhao; Skye Coote; Lauren Pesavento; Leonid Churilov; Helen M Dewey; Stephen M Davis; Bruce C V Campbell Journal: Stroke Date: 2017-03 Impact factor: 7.914
Authors: William J Powers; Colin P Derdeyn; José Biller; Christopher S Coffey; Brian L Hoh; Edward C Jauch; Karen C Johnston; S Claiborne Johnston; Alexander A Khalessi; Chelsea S Kidwell; James F Meschia; Bruce Ovbiagele; Dileep R Yavagal Journal: Stroke Date: 2015-06-29 Impact factor: 10.170
Authors: Lauren Shreve; Arshdeep Kaur; Christopher Vo; Jennifer Wu; Jessica M Cassidy; Andrew Nguyen; Robert J Zhou; Thuong B Tran; Derek Z Yang; Ariana I Medizade; Bharath Chakravarthy; Wirachin Hoonpongsimanont; Erik Barton; Wengui Yu; Ramesh Srinivasan; Steven C Cramer Journal: J Stroke Cerebrovasc Dis Date: 2019-06-04 Impact factor: 2.136
Authors: A T Yu; R W Regenhardt; C Whitney; L H Schwamm; A B Patel; C J Stapleton; A Viswanathan; J A Hirsch; M Lev; T M Leslie-Mazwi Journal: AJNR Am J Neuroradiol Date: 2021-02-04 Impact factor: 3.825